SaaS Metrics
Market Expansion, Nanomedicine Integration
Nuclear Medicine
AI Synthesis & Market Narrative
The nuclear medicine market is projected for robust expansion, driven by demand for diagnostic and therapeutic radiopharmaceuticals in oncology and cardiology. This growth is further fueled by the integration of advanced nanomedicine for targeted cancer immunotherapy, regeneration therapy, and gene editing.
Correlated Linguistic Patterns
["nuclear medicine market"
"diagnostic and therapeutic radiopharmaceuticals"
"oncology
cardiology"
"liposomal nanomedicine"
"nanoparticles for cancer treatment"
"mRNA stability for regeneration therapy and gene editing"]
Driving Media Context
In situ reprogramming of CAR-alveolar macrophages via liposomal nanomedicine for lung cancer immunotherapy
Alveolar macrophages can contribute to systemic anti-tumor responses. Here the authors describe a cascaded targeted liposomal nanomedicine for generating chi...
CTE ruins lives but can’t be confirmed until you’re dead. Canadian scientists are trying to change that
Former soldier Brendan Hynes thinks he has CTE, but the devastating brain disease can’t be confirmed until after someone’s dead. Could cutting-edge Canadian ...
Correction: Phenylboronic acid-modified nanoparticles for cancer treatment
Chem. Commun., 2026, Advance ArticleDOI: 10.1039/D6CC90175A, Correction Open Access   This article is licensed under a Creative Commons Attribution 3.0 U...
Antioxidant lipid nanoparticles enhance mRNA stability for regeneration therapy and gene editing
Here the authors develop an antioxidant lipid nanoparticle to protect mRNA from oxidative damage, enabling stronger, longer-lasting protein expression and im...
Nuclear Medicine Market by Type, Application, Procedure, End User, and Region - Global Forecast to 2030
The global nuclear medicine market is set to expand from USD 10.41 billion in 2025 to USD 21.01 billion by 2030, boasting a CAGR of 15.1%. This robust growth...
Curium Announces a Strategic Investment of Over €32 million in Saclay, France
PARIS, June 01, 2026 (GLOBE NEWSWIRE) -- Curium, a global leader in nuclear medicine, today announced at the Choose France summit in Versailles, a major indu...
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026
LOS ANGELES, May 31, 2026 /PRNewswire/ -- United Imaging, a global innovator in AI-powered advanced medical imaging technologies and intelligent healthcare s...
Rwanda-Russia nuclear deal underscores Africa’s shifting power balance
Rwanda turns to Russia for nuclear training and research, advancing ambitions in technology, healthcare and diplomacy.
SHINE Secures European Marketing Authorization for Ilumira, Latest Step in Building Integrated Nuclear Medicine Platform
European approval opens a major new market for SHINE's non-carrier-added Lu-177 as the company builds an integrated, U.S.-based platform spanning diagnostic ...
RadioMedix to Present at SNMMI 2026 and Mark 20 Years of Radiopharmaceutical Innovation
Company’s SNMMI week activities highlight scientific progress and two decades of advancing precision nuclear medicine for patients with hard-to-treat cancers...